IGF-1 administration in mouse models with methionine-choline-deficient diet-induced nonalcoholic steatohepatitis and dimethylnitrosamine-induced cirrhosis ameliorated hepatic steatosis, inflammation, and fibrosis (25). This evidence concerns the gene IGF1 and Cirrhosis.